ASPIRE BIOPHARMA HOLDINGS, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $300.2M
Liabilities Breakdown FY2022
Total Liabilities: $11.1M
Asset Breakdown
Total Assets: $300.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $497.3K | 0.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $299.7M | 99.8% |
Liabilities Breakdown
Total Liabilities: $11.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $11.1M | 100.0% |